Find Federal Grants

Showing 81–100 of 144 grants
Power tools: Sign in to save searches, get reminders, export CSV, and use advanced filters. Sign in

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-221

Closes: Jan 7, 2027

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-24-325

Closes: Sep 7, 2027

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-079

Closes: Jan 7, 2027 Up to: $500,000 Program funding: $500,000

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-145

Closes: Jan 7, 2028

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-175

Closes: Jan 7, 2028 Up to: $500,000 Program funding: $500,000

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-24-311

Closes: Jan 7, 2028 Up to: $500,000 Program funding: $500,000

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · RFA-NS-25-022

Closes: Sep 28, 2026

BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · RFA-NS-25-021

Closes: Sep 28, 2026

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

★ Save Posted

National Institutes of Health · PAR-25-104

Closes: Oct 25, 2027

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

★ Save Posted

National Institutes of Health · PAR-25-103

Closes: Oct 25, 2027

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-210

Closes: Jun 2, 2027

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-211

Closes: Jun 2, 2027

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-143

Closes: Jan 7, 2028

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-233

Closes: Jan 7, 2028

Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-24-268

Closes: Jan 27, 2027 Up to: $500,000

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-144

Closes: Jan 7, 2028

Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-131

Closes: Apr 15, 2027 Up to: $250,000 Program funding: $250,000

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

★ Save Posted

National Institutes of Health · PAR-24-295

Closes: Dec 3, 2026

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-24-296

Closes: Dec 3, 2026

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-074

Closes: Oct 14, 2026